ABSTRACT
Objective: To assess the demographics of colorectal cancer patients at the King Hussein Medical Center (KHMC) with regard to age, sex, location of primary tumor, and the stage of the tumor.
Methods: A total number of 278 patients were diagnosed with colorectal cancer in the colorectal unit at KHMC over the period from December 2017 to June 2020. Patient’s records were reviewed, and their demographic data were collected such as age, sex, site of tumor, and tumor stage. SPSS version 24 was used to statistically analyze the data.
Results: The mean age of patients was 58 years. The incidence showed a positive relationship with age, with the highest incidence being in the seventh decade. The male to female ratio was 1.59:1. The most common tumor site was the left colon (40%), followed by the right colon (35%) and then the rectum (24%). Most tumors (39.2%) were at stage III at the time of diagnosis, while stage IV tumors were seen in 25.5% of patients, stage II tumors also in 25.5%, and stage I in 4%, Stage 0 tumors were only documented in 1.5% of patients.
Conclusion: Our statistical retrospective results showed a similar pattern with the data from international studies regarding gender distribution and location of tumor, but out patients were more likely to present at younger age and later stages than patients in most other parts of the world, these findings reflect poor adherence to various screening programs. Therefore, improvements in screening protocols and diagnostic tools, as well as enhancing public awareness, might change this distribution, improving the quality of life of colorectal cancer patients and the economic burden for health-related services.
Key words: Colorectal cancer, demographics, stage, Jordan, screening
JRMS April 2024; 31 (1): 10.12816/006175
INTRODUCTION
Colorectal cancer
(CRC) is the third most common malignancy in the world and the second most
common cause of death in cancer patients.(1, 2) The incidence and
mortality of CRC varies widely, with about two thirds of cases occurring in
countries with a high human development index.(3) Variation in the
incidence of CRC is also evident between different races, also residency has an effect on incidence, which supports
the involvement of environmental factors.(4) CRC is more common in
countries with westernized lifestyle practices and has recently been rising
steadily in developing countries.(5, 6) Lifestyle factors, which
include diet, physical activity, alcohol consuming, and tobacco use, may
contribute to an increased risk of getting the disease. These are modifiable
risk factors that can be avoided by increasing physical activities, having a
healthy fiber-rich diet, and avoiding red meat, processed food, alcohol intake,
and smoking. Non-modifiable risk factors include family or personal history,
inflammatory bowel disease, and age. For these factors, the risk of CRC can be
reduced by screening for the early detection of cancer.(7)
The median age at diagnosis is 66 years in men and 69 years in
women, which means that CRC has increased in younger patients in the last 20
years.(8)
Screening can decrease the incidence rate of CRC, through the
removal of precancerous growths, and decreases mortality by the early detection
and removal of cancer. Screening methods include colonoscopy, computed
tomographic colonography, flexible sigmoidoscopy, and stool tests.(8, 9)
The treatment of CRC depends on many factors, including overall
patient health and the site and size of the tumor. Surgery is the main
treatment option, with the type of surgery depending on the tumor site and the
presence of metastasis. Once tumors are beyond surgery, treatment can include
chemotherapy, targeted therapy, radiotherapy, and cryosurgery.(10)
In Jordan, CRC is the second most common cancer in both men and
women. In 2020, a total of 1,260 new cases of CRC were reported by the Globocan
Agency.(11)
The present study analyzes the demographic data of CRC patients at
the King Hussein Medical Center (KHMC).
PATIENTS
AND METHODS
This is a retrospective statistical
analytical study, conducted at KHMC (a major tertiary hospital in Jordan), and
included two hundred seventy-eight patients who were diagnosed with CRC in the
colorectal unit over the period from December 2017 to June 2020. Benign cases
that were diagnosed after surgery were excluded from study. We reviewed the
hospital records for all patients and collected the following data from their
medical files: age, gender, site of tumor, stage of the tumor, and presence of
metastasis at the time of diagnosis. The tumor site was classified as a right
colon tumor for those arising from the cecum, ascending colon, hepatic flexure,
and transverse colon; a left colon tumor for tumors arising from the splenic
flexure, descending colon, and sigmoid colon; and a rectal tumor where the
tumor originated from the rectum. Post-operative staging was performed on
histopathologic specimens and designated from stage 0 to stage IV, according to
the TNM staging system (AJCC Cancer
Staging Manual, Eighth Edition, 2017)12.
Data were statistically analyzed using SPSS version 24. We used the
p value as a measure of significance with alpha level of <0.05. A
chi-square test of independence was performed to examine the relation
between variables. The categorical data were reported as frequency and
percentages.
Ethical committee approval was obtained prior to this study being
conducted (No.4. 7/2021).
RESULTS
The age range for our patients was between twenty and ninety-six
years. There was a male preponderance, with 171 male patients (61.5%) with an
average age of 61.8 years and median 63 years, and 107 female patients (38.5%)
with an average age of 61.7 years and median 64 years. The most common tumor
location in our patients was the left colon with 110 cases (40%), followed by
the right colon, with 97 cases (35%) and then the rectum with 67 cases (24%).
There were 4 cases (1%) in which the tumor was synchronous in multiple sites of
the colon. Seventy-four patients (26.6%) had distant metastasis at the time of
diagnosis. The most common site of metastasis was the liver, being isolated
metastasis in 59% and combined with lung metastasis in 18%, followed by
isolated lung metastasis in 4%, while other sites of distant metastasis (such
as the peritoneum, kidney, adrenals, bone, ovaries, and omentum) were evident
in 14 patients, representing 19% of metastasis. Our analysis did not show a
significant association between the site of the tumor and the incidence of
metastasis, with a p-value of 0.8 (Table 6)
The incidence of CRC increased with age, with a peak in the seventh
decade of life. The age distribution was a little younger in females (Figure
1). The youngest patient was 20 years old, and 13 patients (4.7%) were less
than 40 years of age; the correlation between gender and age in CRC patients
was statistically insignificant with a p value of 0.9.
On evaluation of CRC distribution according to gender, we found
that the most common tumor site in women was the rectum (36%), followed by the
right colon (34%), and the least common site was the left colon, with a
percentage of 30. In men, the tumor distribution was totally different, with
the most common location being the left colon (46%), followed by the right
colon (37%) and then the rectum (17%) (Figure 2). Statistical analysis showed a
significant relationship between gender and the site of the tumor, a chi-square
test of independence showed that there was a significant relation between
gender and site of tumor with p-value of 0.001.
Staging was carried out post-operatively according to the American
Joint Committee of Cancer. Around 39.2% of the patients had CRC stage III at
diagnosis, while 25.5% had stage IV, the same percentage of 25.5% had stage II,
four percent had stage I, and only 1.5% had
stage 0 at time of diagnosis with. Patients with no staging counted 4.3%. Women
showed a slight trend toward the earlier stages than men (Figure 3).
Nevertheless, our statistical analysis showed no significant relationship
between the stage of CRC and gender, with p-value of 0.09.
Table I. Demographics
of patients with colorectal cancer in this study
Parameter
No. of patients N=278 Percentage
Sex
Mean age
58
Male 171
61.5
Female
107
38.5
Location of tumor
Right colon
97
35
Left colon
110
40
Rectum
67
24
Multiple
sites
4
1
Stage
0
4
1.5
I
11 4
II 71 25.5
III
109 39.2
IV
71
25.5
No staging 12 4.3
Figure
I.
Distribution of colorectal cancer according to age
Table II.
Association between gender and age in CRC patients
Variable
|
Age
range in years N= 278 n (%)
|
N
(%)
|
Chi
square
|
p
value
|
|
20-30
|
30-40
|
40-50
|
50-60
|
60-70
|
70-80
|
>80
|
Gender
|
|
10.695
|
0.098
|
Male
|
1
(0.6)
|
4
(2.3)
|
19
(11.2)
|
37
(21.6)
|
51
(29.8)
|
47
(27.5)
|
12
(7)
|
171
(61.5)
|
|
|
Female
|
0
|
8
(7.5)
|
22
(20.6)
|
22
(20.6)
|
27
(25.2)
|
23
(21.5)
|
5
(4.6)
|
107
(38.5)
|
|
|
N
(%)
|
1
(0.4)
|
12
(4.3)
|
41
(14.7)
|
59
(21.2)
|
78
(28.1)
|
70
(25.2)
|
17
(6.1)
|
278
|
|
|
Figure
III.
Distribution of colorectal cancer stage at time of diagnosis
Table IV.
Association between gender and stage of tumor
Variable
|
Stage N= 266 n (%)
|
N (%)
|
Chi square
|
p value
|
Stage 0
|
Stage 1
|
Stage 2
|
Stage 3
|
Stage 4
|
Gender
|
|
0.5785
|
0.965
|
Male
|
2
(1.2)
|
6
(3.7)
|
43
(26.5)
|
66
(40.8)
|
45
(27.8)
|
162 (61)
|
|
|
Female
|
2
(1.9)
|
5
(4.8)
|
28
(26.9)
|
43
(41.3)
|
26
(25.1)
|
104 (39)
|
|
|
N (%)
|
4 (1.5)
|
11 (4.1)
|
71 (26.7)
|
109 (41)
|
71 (26.7)
|
266
|
|
|
Figure IV. Stages of tumor in age groups
Table V.
Association between stage of tumor and age
Variable
|
Stage N=266 n (%)
|
N (%)
|
Chi square
|
p value
|
|
Stage 0
|
Stage 1
|
Stage 2
|
Stage 3
|
Stage 4
|
Age
|
3.6325
|
0.458
|
<60 years
|
1
(0.9)
|
2
(1.9)
|
28
(25.9)
|
49
(45.4)
|
28
(25.9)
|
108 (40.6)
|
|
|
>60 years
|
3
(1.9)
|
9
(5.7)
|
43
(27.2)
|
60
(38)
|
43
(27.2)
|
158 (59.4)
|
|
|
N (%)
|
4 (1.5)
|
11 (4.1)
|
71 (26.7)
|
109 (41)
|
71 (26.7)
|
266
|
|
|
Table VI.
Association between site of tumor and the incidence of metastasis
Variable
|
Site of Tumor N=274 n (%)
|
N (%)
|
Chi square
|
p value
|
|
Right colon
|
Left colon
|
Rectosigmoid
|
Presence of Mets
|
0.3143
|
0.854
|
Metastasis
|
24
(32.9)
|
31
(42.4)
|
18
(24.7)
|
73
(26.6)
|
|
|
No metastasis
|
73
(36.3)
|
79
(39.3)
|
49
(24.4)
|
201 (73.4)
|
|
|
N (%)
|
97 (35.5)
|
110 (40)
|
67 (24.5)
|
274
|
|
|
DISCUSSIONS
In this study we have investigated the demographics of CRC in
Jordan which showed younger age presentation. This finding necessitates the
implementation of screening program for CRC in Jordan.
Cancer in Jordan has steadily increased in the last two decades.(13)
On a collective basis, the most frequent cancers in both genders are breast,
colorectal, lymphoma, lung, and leukemia.(14) In Western Asia,
Jordan is considered as one of the countries with the highest incidence of CRC,
along with Lebanon and Turkey, due to an increased prevalence of obesity, unhealthy
dietary habits, decreased physical activities, a sedentary lifestyle, and
smoking.(15)
CRC in Jordan ranks second in the list of cancers in both genders.(11,
14) Our study showed that the highest incidence is in the group aged
60-70 years, which is in accordance with a previous study in Jordan in 1997 and
with other studies in the literature.( 16, 17, 18) The mean age of
our patients was 58 years, which is lower than that reported in western
countries and could be explained by the younger age of the Jordanian
population.( 17, 18, 19) It has been reported that younger age at
diagnosis is associated with a more advanced stage, which is in parallel with
this study, where the percentage of patients younger than 60 years with late
stage (III & IV) CRC was 71%, while that for patients older than 60 was
63%.(20)
The left colon was the most frequent site for CRC in our patients,
which is in agreement with Fazeli et al. (2007) but in disagreement with
Griffith et al. (2021).(21, 22) Regarding the gender of patients,
there was a male predominance of 61.5%, as reported in most other studies.(8,
16, 21, 23) The distribution of the CRC tumor location differed between
men and women, with a predominance of the left colon in men and the right colon
in women, which is in accordance with the literature.(24, 25) Right
colon tumors are usually associated with a late presentation, more aggressive
behavior and a higher mortality than other tumor sites.(26) Both
genders showed similar percentages of stage IV CRC, with 24% in females and 26%
in males, which is against expectation, because women are more likely to have a
right colon tumor, which tends to present in an advanced stage at the time of
diagnosis.(24)
The
median age at diagnosis is 63.5 years for right CRC and 64 years for left colon
and rectal tumors, which is a little different from the data reported by Kim SE
et al. (2015) and other studies in the literature, where the age of patients
increased in association with a shift in the anatomical site of origin of the
CRC from the left colon to the right colon.(24, 25, 26)
The
majority of the patients in this study presented in advanced stages III and IV
(38.8% and 25.5%, respectively), which means that most patients present late with
symptoms, reflecting poor adherence to screening protocols. These findings were
in agreement with a study conducted in the Caribbean Island of Barbados on 97
CRC patients.(22)
The
liver was the most common site for metastasis, followed by the lung and
peritoneum. Other sites of metastasis were bone, ovaries, kidneys, adrenals,
spleen, and brain. We did not notice a difference in the sites of metastasis
between the right and left colon, which is inconsistent with Engstrand et al.
(2018) who reported that liver metastasis was more frequent in left CRC.(27)
Conclusion
Our
statistical retrospective results showed a similar pattern with the data from
international studies regarding gender distribution and location of tumor, but out patients were more likely to present
at younger age and later stages than patients in most other parts of the world,
these findings reflect poor adherence to various screening programs. Therefore,
improvements in screening protocols and diagnostic tools, as well as enhancing
public awareness, might change this distribution, improving the quality of life
of colorectal cancer patients and the economic burden for health-related
services.
Limitations of the study
The
main limitation in this study is that some data are missing because of loss of
follow up of some patients in Royal Medical Services hospitals.
References:
1)
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., et
al. (2017)
Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66, 683-691.
2)
Høydahl, Ø., Edna, T. H.,
Xanthoulis, A., Lydersen, S., & Endreseth, B. H. (2020) Long-term trends in
colorectal cancer: incidence, localization, and presentation. BMC Cancer,
20, 1077.
3)
C. S., Wong, M., Huang, J., Lok, V., Wang, J., Fung, F., et al. (2020) Differences
in incidence and mortality trends of colorectal cancer worldwide based on sex,
age, and anatomic location. Clinical Gastroenterology and Hepatology, 19, 955-966.
4)
Boyle, P. & Leon, M. E. (2002)
Epidemiology of colorectal cancer. British Medical Bulletin, 64, 1-25.
5)
Khil, H., Kim, S. M., Hong, S. E.,
Gil, H. M., Cheon, E., et al. (2021) Time trends of colorectal cancer incidence
and associated lifestyle factors in South Korea. Scientific Reports, 11, 2413.
6)
Janout V, Kollárová H. Epidemiology
of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001
Sep;145(1):5-10.
7)
Colorectal Cancer Facts &
Figures 2020-2022, American Cancer Society, 2020 http://cancerstatisticscenter.cancer.org.
8)
Rawla, P., Sunkara, T., &
Barsouk, A. (2019) Epidemiology of colorectal cancer: incidence, mortality,
survival, and risk factors. Gastroenterology Rev, 14(2), 89-103.
9)
Marley, A. R. & Nan, H. (2016)
Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet, 7(3),
105-114.
10)
World Health Organization (WHO):
Globocan Statistics 2020. WHO, Geneva, 2020. https://gco.iarc.fr/today/data/factsheets/populations/400-jordan-fact-sheets.pdf. Accessed March,
2021.
11)
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, et al. AJCC Cancer Staging Manual (8th edition). Spring
International Publishing: American Joint Commission on Cancer; 2017 [cited 2016
Dec 28].
12)
Abdel-Razeq H, Attiga F, Mansour A.
Cancer care in Jordan. Hematology/oncology and Stem Cell Therapy. 2015
Jun;8(2):64-70.
13)
Roshandel, G., MD, Boreiri, M,.
Sadjadi, A., & Malekzadeh, R. (2014) A diversity of cancer incidence and
mortality in west Asian populations. Ann Glob Health, 80(5), 346-57.
14)
Sharkas, G., Arqoub, K., Khader,
Y., Tarawneh, M., & Nimri, O. (2017) Colorectal cancer in Jordan: survival
rate and its related factors. Hindawi Journal of Oncology, 2017, Article ID
3180762, 6 pages.
15)
Al-Jaberi, T., Ammari, F.,
Gharieybeh, K., Khammash, M., Yaghan, R., et al. (1997) Colorectal
adenocarcinoma in a defined Jordanian population from 1990 to 1995. Dis
Colon Rectum, 1(40)9, 1089-1094.
16) Rampersad,
M. K., Mohammed, S. R., & Jurawan, R. (2017) A single centre retrospective
review of colorectal cancer in Trinidad over a three year period. Gastroenterol
Hepatol Open Access, 8(1), 6-8.
17)
Moghadamyeghaneh, Z., Alizadeh, R.
F., Phelan, M., Carmichael, J. C., Mills, S. et al. (2016) Trends in colorectal
cancer admissions and stage at presentation - impact of screening. Surg
Endosc, 30(8), 3604-3610.
18)
Gabriel, E., Attwood, K., Al-Sukhni, E., Erwin, D., Boland, P. et al. (2018) Age-related rates
of colorectal cancer and the factors associated with overall survival. J
Gastrointest Oncol, 9(1), 96-110.
19)
Fazeli, M. S., Adel, M. G., &
Lebaschi, A. H. (2007) Colorectal carcinoma: a retrospective, descriptive study
of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001
as observed in Tehran University. Dis Colon Rectum, 50, 990-995.
20)
Griffith, S., Padmore, G., Phillips,
E., Ramkissoon, S., Moore, S. et al. (2021) Colorectal cancer demographics in
Barbados. Medicine International, 1, 2.
21)
Center, M., Jemal, A., & Ward,
E. (2009) International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev, 18(6).
22)
Hansen, I. O. & Jess, P. (2021)
Possible better long-term survival in left versus right-sided colon cancer – a
systematic review. Dan Med J, 59(6), A4444.
23)
Baran, B., Ozupek, N. M., Tetik, N. Y., Acar, E., Bekcioglu, O. et al. (2018) Difference
between left-sided and right-sided colorectal cancer: a focused review of
literature. Gastroenterol Res, 11(4), 264-273.
24)
Kim, S. E., Paik, H. E., Yoon, H.,
Lee, J. E., Kim, N. et al. (2015) Sex- and gender-specific disparities in
colorectal cancer risk. World J Gastroenterol, 21(17), 5167-5175.
25)
Engstrand, J., Nilsson, H.,
Strömberg, C., Jonas, E., & Freedman, J. (2018) Colorectal cancer liver
metastases–a population-based study on incidence, management and survival.
BMC Cancer, 18, 78.